An index of captured practitioner sources, not a completed evidence summary. Unchecked figures and empty sections are omitted. See the library review status.
Source summary generated November 6, 2026; this date does not indicate completed review.
Hormones169 cited mentionsAliases: Human Menopausal Gonadotropin
Quotes from three independent practitioners, with their sources. Research context only.
What it is and how it works
From the published literature on HMG; the papers are listed at the end. Research summary, not a recommendation.
What it is
Human menopausal gonadotropin (hMG, menotropins) is a mixture of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) activity purified from the urine of postmenopausal women, whose pituitaries secrete large amounts of both. It was introduced in the 1960s and remains a prescription fertility drug; modern preparations are highly purified and part of the LH activity comes from hCG that co-purifies.
How it works
FSH acts on Sertoli cells in the testis to drive sperm production and on granulosa cells in the ovary to grow follicles; LH acts on Leydig cells to make testosterone and on theca cells to make the androgen precursors of estrogen. hMG supplies both signals from outside the body, so it can replace a missing pituitary signal (hypogonadotropic hypogonadism) or push the ovary to grow several follicles at once for IVF. In men it is usually combined with hCG once testosterone has been restored and sperm production has not started.
What it has been studied for
Inducing sperm production in men with hypogonadotropic hypogonadism (with hCG)
Controlled ovarian stimulation for IVF and ovulation induction in women
Pubertal induction in boys with gonadotropin deficiency
Comparison against recombinant FSH in assisted reproduction
Strength of the evidence
Approved drugMenotropins are FDA-approved for ovulation induction, assisted reproduction and spermatogenesis induction, supported by Cochrane meta-analyses and clinical series.
What the literature reports on safety
The main risks are ovarian hyperstimulation syndrome, multiple pregnancy and injection-site reactions in women; in men gynecomastia and acne have been reported. It is contraindicated in primary gonadal failure, uncontrolled thyroid or adrenal disease and hormone-dependent tumors. It requires monitoring with hormone levels and ultrasound.
“HMG comes in when HCG alone doesn't increase sperm counts after 3 to 6 months. Typical dose is 75 to 150 IU two to three times weekly. I'm doing 75 IU three times a week, so 225 IU per week.”
5 earlier videos were removed from YouTube; titles kept for the record
The Proof That Healthcare is a Business - Unbreakable Podcast 200 (6×) · 2025-07-20
The Lie About High Cholesterol - Unbreakable Podcast 263 (6×) · 2025-09-24
The FDA War Against Peptides and The Facts - Dr Trevor Bachmeyer (6×) · 2026-02-13
Why You Can't Talk About It - Unbreakable Podcast 257 (3×) · 2025-09-18
KPV and TB500N vs Cholesterol, AFib and Heart Disease - Dr Trevor Bachmeyer (3×) · 2026-03-22
Ask the HMG Librarian
Answers are generated from captured sources and may omit context or contain errors. Check the supporting passages.
What have the teachers said about HMG? Ask what it is, what they say it does, or where they discuss it. Questions about doses or personal use: ask your own clinician.
AI chat. To generate a reply, your question and recent chat history may be processed by Cloudflare Workers AI, Groq, Google Gemini or OpenRouter, depending on availability. Keep personal health details out of the chat and check the cited sources. Research use only; not medical advice.
All content on this page is for research and educational purposes only and is not intended as medical advice. Always consult a qualified healthcare provider before starting any peptide or hormone protocol. You take responsibility for your own protocol.If your path includes peptides, you buy them yourself from an independent licensed provider through a member co-op; we take nothing. How independent access works.